The declining federal funding for disease surveillance poses significant risks, particularly as old diseases like tuberculosis begin to resurge. Effective surveillance is crucial for tracking and controlling infectious diseases. With diminishing resources, public health agencies may struggle to respond adequately to potential outbreaks, hampering their ability to monitor and manage both emerging and re-emerging pathogens.